Viewing Study NCT01373294


Ignite Creation Date: 2025-12-25 @ 1:35 AM
Ignite Modification Date: 2026-01-03 @ 1:32 AM
Study NCT ID: NCT01373294
Status: COMPLETED
Last Update Posted: 2019-08-06
First Post: 2011-06-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MCC-16295
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View